Francesco Maura, M.D. (IMAGE) University of Miami Miller School of Medicine Caption “Recognizing these mutations and gaining a clearer understanding of the resistance mechanisms to these potent immunotherapies is pivotal,” said Francesco Maura, M.D., whose lab at Sylvester conducts myeloma computational and translational research. “This knowledge plays a crucial role in devising tailored strategies and making informed choices regarding the selection of products and targets for individual patients.” Credit Photo by Sylvester Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.